L. Trzeciak et al., Mutations, methylation and expression of CDKN2 alpha/p16 gene in colorectal cancer and normal colonic mucosa, CANCER LETT, 163(1), 2001, pp. 17-23
The status of CDKN2 alpha gene, coding for p16 and p19ARF proteins, was exa
mined in 55 colorectal cancers. Polymerase chain reaction (PCR), single str
anded conformational polymorphism and sequencing revealed 1 case of CDKN2 a
lpha mutation. Methylation-specific PCR detected p16 locus methylation in 3
7 (73%) of 51 normal samples and 29 (53%) of 55 cancers (P = 0.035). p16 tr
anscript absence (assessed by reverse transcription-polymerase chain reacti
on) was noted in 10 (45%) of 22 normal samples and four (14%) of 29 cancers
(P = 0.012) and correlated with gene methylation (P = 0.036). The decreasi
ng frequency of p16 silencing in cancer comparing to normal mucosa does not
support the postulated role of p16 in colorectal carcinogenesis. (C) 2001
Elsevier Science Ireland Ltd. All rights reserved.